Effects of Hydrotherapy on Unilateral Lower Extremity Lymphedema
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorGaziosmanpasa Research and Education Hospital
About this trial
Lymphedema is a chronic condition that negatively affects patients' quality of life and lower extremity functions, causing swelling and a feeling of heaviness in the extremity, as well as posing an economic burden. The gold standard in lymphedema treatment is complex decongestive therapy.Manual lymphatic drainage, skin care, the use of compression garments, and home exercise programs play an important role. Exercise therapies lead to a reduction in volume and an improvement in functionality and quality of life in patients with lymphedema. However, studies on this subject have mostly focused on upper extremity lymphedema. This study aims to compare the effects of a home exercise program and hydrotherapy combined with a home exercise program on quality of life, lower extremity functionality, exercise capacity, and edema severity in patients with unilateral lower extremity lymphedema
Eligibility criteria
Qualifiers
Patients with primary or secondary unilateral lower extremity lymphedema diagnosis
Patients who have received at least 2 weeks of complex decongestive therapy in the past
Patients who are cooperative with hydrotherapy treatments
Patients who are willing to participate in the treatment
Disqualifiers
Patients who are unable to perform the evaluation parameters
Patients with serious systemic diseases that may prevent exercise
Patients who have had an injury and/or surgery in the last 6 months
Conditions where hydrotherapy is contraindicated (severe fear of water, behavioral problems, shortness of breath at rest, incontinence, known chlorine allergy, open wound, acute systemic illness, epilepsy, tracheostomy, permanent drain, immunodeficiency)
Trial design
Treatments tested in this trial
- Interventional group
- Control group
Treatment groups
52 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov